Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease

Clinical trial NCT07753200 · RECRUITING

Trial details

NCT number: NCT07753200
Sponsor: Samsung Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation (AF)Coronary Arterial Disease (CAD)

Start date: 2026-07-20
Primary completion: 2031-06-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.